INDO US BIOTECH
Quarterly Results Analysis [Mar2026]
INDO US BIOTECH Quarterly Results
| Standalone | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹26 Cr | ₹23 Cr | ₹31 Cr | ₹31 Cr | ₹33 Cr | ₹24 Cr | ₹22 Cr | ₹25 Cr |
| Expenses | ₹23 Cr | ₹19 Cr | ₹27 Cr | ₹25 Cr | ₹29 Cr | ₹18 Cr | ₹17 Cr | ₹21 Cr |
| Operating Income | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Profit Before Tax | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr |
| Profit After Tax | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr |
| EPS | ₹0.98 | ₹1.49 | ₹1.72 | ₹2.35 | ₹1.84 | ₹2.52 | ₹2.17 | ₹1.58 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| INDO US BIOTECH | -1.9% | -9% | -43.4% |
| KAVERI SEED COMPANY | -1.3% | -14% | -40.3% |
| VENKYS (INDIA) | -2.3% | -11.9% | -13% |
| AVT NATURAL PRODUCTS | -0.2% | 1.9% | 5.3% |
| BOMBAY SUPER HYBRID SEEDS | -3.9% | NA | NA |
| MANGALAM GLOBAL ENTERPRISE | 1% | 11.9% | 16.3% |
| NATH BIOGENES (INDIA) | -4.4% | -3.8% | -7.4% |
| JK AGRI GENETICS | -4.1% | -8.4% | -14.8% |
| MANGALAM SEEDS | -7.7% | -14.6% | -29.1% |
INDO US BIOTECH Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 14.15 % |
| Y-o-Y | -22.05 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹26 Cr | 14.15 | |
| Dec2025 | ₹23 Cr | -26.09 | |
| Sep2025 | ₹31 Cr | 0.25 | |
| Jun2025 | ₹31 Cr | -7.83 | |
| Mar2025 | ₹33 Cr | 41.68 | |
| Dec2024 | ₹24 Cr | 6.27 | |
| Sep2024 | ₹22 Cr | -10.30 | |
| Jun2024 | ₹25 Cr | - | |
INDO US BIOTECH Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -22.24 % |
| Y-o-Y | -29.57 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3 Cr | -22.24 | |
| Dec2025 | ₹4 Cr | -0.29 | |
| Sep2025 | ₹4 Cr | -23.91 | |
| Jun2025 | ₹5 Cr | 19.38 | |
| Mar2025 | ₹5 Cr | -17.29 | |
| Dec2024 | ₹6 Cr | 8.18 | |
| Sep2024 | ₹5 Cr | 38.77 | |
| Jun2024 | ₹4 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -31.91 % |
| Y-o-Y | -9.69 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 12.4% | -31.91 | |
| Dec2025 | 18.21% | 34.89 | |
| Sep2025 | 13.5% | -24.07 | |
| Jun2025 | 17.78% | 29.50 | |
| Mar2025 | 13.73% | -41.60 | |
| Dec2024 | 23.51% | 1.77 | |
| Sep2024 | 23.1% | 54.72 | |
| Jun2024 | 14.93% | - | |
INDO US BIOTECH Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -34.27 % |
| Y-o-Y | -46.54 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2 Cr | -34.27 | |
| Dec2025 | ₹3 Cr | -13.18 | |
| Sep2025 | ₹3 Cr | -26.60 | |
| Jun2025 | ₹5 Cr | 27.63 | |
| Mar2025 | ₹4 Cr | -27.10 | |
| Dec2024 | ₹5 Cr | 15.94 | |
| Sep2024 | ₹4 Cr | 37.58 | |
| Jun2024 | ₹3 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -42.43 % |
| Y-o-Y | -31.43 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 7.57 % | -42.43 | |
| Dec2025 | 13.15 % | 17.52 | |
| Sep2025 | 11.19 % | -26.77 | |
| Jun2025 | 15.28 % | 38.41 | |
| Mar2025 | 11.04 % | -48.53 | |
| Dec2024 | 21.45 % | 9.10 | |
| Sep2024 | 19.66 % | 53.35 | |
| Jun2024 | 12.82 % | - | |
INDO US BIOTECH Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -34.23 % |
| Y-o-Y | -46.74 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹0.98 | -34.23 | |
| Dec2025 | ₹1.49 | -13.37 | |
| Sep2025 | ₹1.72 | -26.81 | |
| Jun2025 | ₹2.35 | 27.72 | |
| Mar2025 | ₹1.84 | -26.98 | |
| Dec2024 | ₹2.52 | 16.13 | |
| Sep2024 | ₹2.17 | 37.34 | |
| Jun2024 | ₹1.58 | - | |
You may also like the below Video Courses
KAVERI SEED COMPANY LTD vs VENKYS (INDIA) LTD vs AVT NATURAL PRODUCTS LTD
BOMBAY SUPER HYBRID SEEDS LTD vs MANGALAM GLOBAL ENTERPRISE LTD vs NATH BIOGENES (INDIA) LTD